Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ: RCKT · Real-Time Price · USD

3.250

-0.150 (-4.41%)

At close: May 15, 2026, 4:00 PM EDT

3.270

+0.020 (0.62%)

After-hours: May 15, 2026, 7:34 PM EDT

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	49.61	77.56	163.64	55.9	140.52	232.69
Short-Term Investments	94.77	111.37	208.7	317.27	215.88	156.05
Cash & Short-Term Investments	144.38	188.93	372.34	373.18	356.39	388.74
Cash Growth	-54.62%	-49.26%	-0.22%	4.71%	-8.32%	-19.47%
Other Current Assets	5.45	3.81	5.85	5.05	7.67	3.32
Total Current Assets	149.83	192.73	378.18	378.22	364.06	392.06
Net Property, Plant & Equipment	69.45	71.59	83.32	87.59	77.65	72.35
Other Intangible Assets	25.15	25.15	25.15	25.15	25.72	-
Goodwill	39.15	39.15	39.15	39.15	39.15	30.82
Long-Term Investments	-	-	-	34.32	43.28	-
Other Long-Term Assets	1.82	1.82	1.89	1.91	1.95	1.8
Total Assets	285.41	330.45	527.7	566.34	551.81	497.02
Accounts Payable	21.54	27.29	37.83	45.79	36.66	19.62
Current Portion of Leases	2.92	2.92	2.86	2.72	2.51	2.55
Total Current Liabilities	24.47	30.21	40.68	48.51	39.17	22.17
Long-Term Leases	21.84	21.96	22.64	22.33	20.36	20.05
Other Long-Term Liabilities	1.06	1.06	1.14	2.94	2.6	0.08
Total Long-Term Liabilities	22.9	23.02	23.78	25.26	22.95	20.13
Total Liabilities	47.37	53.23	64.47	73.77	62.12	42.3
Common Stock	1.09	1.08	1.07	0.9	0.79	0.65
Treasury Stock	-	-	-	-	-0.05	-
Additional Paid-in Capital	1,726	1,717	1,680	1,451	1,203	946.15
Accumulated Other Comprehensive Income	-0.11	-0.03	0.07	0.32	-0.36	-0.16
Retained Earnings	-1,489	-1,441	-1,218	-959.37	-713.78	-491.91
Shareholders' Equity	238.04	277.22	463.23	492.57	489.69	454.72
Total Liabilities & Equity	285.41	330.45	527.7	566.34	551.81	497.02
Total Debt	24.76	24.88	25.5	25.04	22.87	22.6
Net Cash (Debt)	119.62	164.05	346.84	348.13	333.53	366.14
Net Cash Growth	-27.09%	-52.70%	-0.37%	4.38%	-8.91%	-13.04%
Net Cash Per Share	1.07	1.48	3.66	4.14	4.89	5.79
Book Value	238.04	277.22	463.23	492.57	489.69	454.72
Book Value Per Share	2.13	2.49	4.89	5.86	7.19	7.19
Tangible Book Value	173.74	212.92	398.93	428.27	424.81	423.91
Tangible Book Value Per Share	1.56	1.92	4.21	5.10	6.23	6.70

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q